Nabil Amirouchene-Angelozzi

1.3k citations
6 papers · 420 indexed · h-index 6
Topics
Cancer Genomics and Diagnostics (3 papers)Cancer Immunotherapy and Biomarkers (2 papers)Ocular Oncology and Treatments (2 papers)

In The Last Decade

Nabil Amirouchene-Angelozzi

6 papers receiving 417 citations

Peers

Nabil Amirouchene-Angelozzi
Comparison fields: 5 of 49
  • Molecular Biology 207
  • Oncology 177
  • Cancer Research 146
  • Ophthalmology 121
  • Pathology and Forensic Medicine 83
Replace Berglind O. Einarsdottir with:
Berglind O. Einarsdottir Sweden
Ingrid Lebigot France
Alexandre Houy France
Judith Symmons Australia
Irsan Kooi Netherlands
Samar Alsafadi France
Lisa Roberts-Rapp United States
Nikia A. Laurie United States
James Freeman Australia
Ruud van der Noll Netherlands
Nabil Amirouchene-Angelozzi relative to Berglind O. Einarsdottir Sweden Berglind O. Einarsdottir's profile →
Citations per field
00.5×1.5×1.8×
Berglind O. Einarsdottir · 1×
Citations per year

Countries citing papers authored by Nabil Amirouchene-Angelozzi

Since Specialization
Citations

This map shows the geographic impact of Nabil Amirouchene-Angelozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Amirouchene-Angelozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Amirouchene-Angelozzi more than expected).

Fields of papers citing papers by Nabil Amirouchene-Angelozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Amirouchene-Angelozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Amirouchene-Angelozzi. The network helps show where Nabil Amirouchene-Angelozzi may publish in the future.

Co-authorship network of co-authors of Nabil Amirouchene-Angelozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil Amirouchene-Angelozzi. A scholar is included among the top collaborators of Nabil Amirouchene-Angelozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil Amirouchene-Angelozzi. Nabil Amirouchene-Angelozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 38
2 14
3 87
4 136
5 36
6 109

About Nabil Amirouchene-Angelozzi

Nabil Amirouchene-Angelozzi is a scholar working on Ophthalmology, Cancer Research and Oncology, having authored 6 papers that have together received 420 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Ocular Oncology and Treatments (2 papers). The work is most often cited by research in Ophthalmology (121 citations), Cancer Research (146 citations) and Oncology (177 citations). Nabil Amirouchene-Angelozzi has collaborated with scholars based in Italy, France and United Kingdom. Frequent co-authors include Alberto Bardelli, Charles Swanton, Giuseppe Rospo, Giovanni Germano, David Gentien, Didier Decaudin, Fariba Némati, Sergio Roman‐Roman, Sophie Piperno‐Neumann and Laurence Desjardins. Their work appears in journals such as Journal of Clinical Oncology, Cancer Discovery and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026